The study of Graft vs. Host Disease-Competitive Landscape, Technology and Pipeline Analysis, 2017 is very important to enhance business productivity and for the study of market forecast. This New Report presented by Orbis Reseach contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Attractive Discount Details on Purchase of This Report:
Get Flat 15% on Single User License, Flat 25% on Site License & Flat 30% on Enterprise Licence
offer Last 30th June
“Graft vs. Host Disease- Competitive Landscape, Technology and Pipeline Analysis, 2016”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under the category of Graft Versus Host Disease. Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. The complexity of immune-mediated disease occurs due to the interaction between the adaptive immunity of donor and recipient. It can progress from mild to severe forms as either acute GVHD (aGVHD) or chronic GVHD (cGVHD). Both aGVHD and cGVHD commonly affect organs such as the skin, gastrointestinal (GI) tract, liver, oral mucosa, and eyes. It is the worldwide cause of mortality and morbidity. Several factors are responsible for Graft versus Host Disease such as blood transfusion, bone marrow transplant, stem cell transplant.
This report provides information on the therapeutic development based on the Graft versus Host Disease dealing with around 57 active pipeline drugs. The report also covers the information for 53 active companies involved in the therapeutic development of the products.
Get a PDF Sample of Report at: http://www.orbisresearch.com/contacts/request-sample/209352 .
The new report, provides a Graft Versus Host Disease Landscape across the globe
The report provides drug profiles which includes product description, MOA, licensors & collaborators, development partner and chemical information
Comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, Preclinical and Discovery stages
Coverage of the Graft Versus Host Disease pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
The report reviews key players involved in the therapeutics development for Graft Versus Host Disease and also provide company profiling
Pipeline products coverage based on various stages of development from NDA filings to discovery.
Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type.
Place a Purchase Order for this Report at: http://www.orbisresearch.com/contact/purchase/209352 .
Table Of Content:
Risk factors of GvHD
Grading system of GVHD
Treatment algorithm for GVHD
Management of Graft versus Host Disease
Targets of Graft vs. Host Disease and Analysis
Graft Versus Host Disease Collaborations and Deal Year
Graft Versus Host Disease Collaborations and Deal value
Companies’ Licensing Agreement for Graft Versus Host Disease
Financing details of Graft Versus Host Disease
Companies received Grants for Graft vs. Host Disease
Clinical trials analysis with completion year
Graft Versus Host Disease Technologies
Therapeutics under Development by Companies
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research